Fund Holdings — Merck & Co., Inc.

Total Portfolio Value:
$164.28M
Total Bought:
$1.79M
Total Sold:
$2.62M
Net Transaction:
-$827.5K
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Moderna, Inc.(MRNA)2,308,1902,308,1900$95.97M$65.44M39.83%-$30.54M
Personalis, Inc.(PSNL)14,044,94314,044,9430$81.18M$49.30M30.01%-$31.88M
Kymera Therapeutics, Inc.(KYMR)772,165772,1650$31.06M$21.13M12.86%-$9.93M
Entrada Therapeutics, Inc.(TRDA)1,739,7681,739,7680$30.08M$15.73M9.57%-$14.35M
Alector Inc3,545,7193,545,7190$6.70M$4.36M2.65%-$2.34M
Evaxion Biotech A/sADS542,2791,214,126+671,847$458.4K$2.25M1.37%+$1.79M
Sutro Biopharma, Inc.(STRO)2,723,5092,723,5090$5.01M$1.77M1.08%-$3.24M
Lava Therapeutics NvSHS1,149,3451,149,3450$1.09M$1.46M0.89%+$366.6K
Viridian Therapeutics, Inc.(VRDN)93,41493,4140$1.79M$1.26M0.77%-$531.5K
Xilio Therapeutics, Inc.(XLO)1,483,7581,483,7580$1.42M$1.07M0.65%-$342.2K
Carisma Therapeutics Inc1,473,2401,473,2400$617.0K$456.7K0.28%-$160.3K
Neuphoria Therapeutics Inc10,02710,0270$34.4K$57.8K0.04%+$23.4K
Absci Corporation998,1630-998,163$2.62M$0—-$2.62M
Page 1 of 1
Merck & Co., Inc. — 13F Holdings — Q1 2025 | TickerTrail